
GLPGF
Healthcare · Biotechnology · $2.32B market cap
$35.150.00 (0.0%)Nov 13, 9:30 AM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Aug 10, 2026 | After the close | -0.43 | 0.04 | +108.1% |
| May 6, 2026 | After the close | — | 0.25 | — |
| Nov 5, 2025 | After the close | -0.01 | -3.58 | -35740.0% |
| Jul 23, 2025 | After the close | -0.41 | -1.82 | -344.0% |
| Apr 30, 2025 | Before the open | — | -2.45 | — |
| Mar 27, 2025 | Time not confirmed | — | 0.29 | — |
| Oct 31, 2024 | Before the open | — | -0.84 | — |
| Aug 1, 2024 | Before the open | — | 0.15 | — |
| May 2, 2024 | Before the open | — | 1.49 | — |
| Feb 23, 2023 | After the close | -0.53 | -3.16 | -496.2% |
| Nov 3, 2022 | After the close | -0.80 | 0.33 | +141.3% |
| Aug 4, 2022 | After the close | -0.82 | -0.29 | +64.6% |
| May 5, 2022 | After the close | -1.06 | -0.20 | +81.1% |
Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667, which is in a phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in a phase 1/2 trial in…
| Feb 24, 2022 | After the close | -0.64 | 0.25 | +139.1% |
| Nov 4, 2021 | After the close | -1.31 | -0.99 | +24.4% |
| Aug 5, 2021 | After the close | -0.87 | -0.98 | -12.6% |
| May 6, 2021 | After the close | -0.55 | 0.14 | +125.5% |
| Feb 18, 2021 | After the close | -0.95 | -0.88 | +7.4% |
| Nov 5, 2020 | After the close | -0.60 | -1.25 | -108.3% |
| Aug 6, 2020 | After the close | -0.33 | -1.77 | -436.4% |
| May 6, 2020 | After the close | -0.42 | -0.78 | -85.7% |
| Feb 20, 2020 | After the close | 0.39 | -2.10 | -638.5% |
| Oct 24, 2019 | After the close | -0.52 | 6.03 | +1259.6% |
| Jul 25, 2019 | After the close | -1.13 | -0.86 | +23.9% |
| Apr 25, 2019 | After the close | -0.97 | -0.89 | +8.2% |
| Feb 21, 2019 | Before the open | -0.60 | 0.27 | +145.0% |
| Oct 24, 2018 | After the close | -0.62 | 0.28 | +145.2% |
| Aug 2, 2018 | After the close | -0.58 | -0.42 | +27.6% |
| Apr 25, 2018 | Before the open | -0.96 | -0.73 | +24.0% |
| Feb 22, 2018 | Before the open | -0.06 | -0.59 | -883.3% |